skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: One gets weary of the seemingly endless legal battles that JNJ continues to suffer. I have held on to shares assuming all sides would surely give in to battle-fatigue. My assumption looks wrong, especially after yet another defeat by JNJ on Friday July 28. Worth holding or move on? As always, your opinion backed by your own reasoning would be much appreciated. If you think best trim or sell, what dividend payer in health care would you favor today (US only).
Read Answer Asked by Adam on August 02, 2023
Q: ABBV is approx. 28% off it's high of last year. I am considering a change to one of LLY; ILMN; or ISRG. Do you concur with the change and if so which would you prefer.

Carl
Read Answer Asked by Carl on August 02, 2023
Q: I would like to increase my exposure to US large cap healthcare, currently own PFE and ISRG. Can you recommend another company that would be complementary to these holdings or would you simply add to the existing positions? Also own some smaller names in this sector e.g. WELL but am interested in increasing the large cap exposure. Thank you.
Read Answer Asked by Barbara on August 01, 2023
Q: I have a largish position in JNJ and see there is an offer to exchange some or all for a stake in KVUE at a 7% market discount which puts cost close to the IPO price of KVUE based on July 24 AM market price.

What to do - exchange some or all, ignore or buy KVUE separately rather than end up with a likely odd lot?
Read Answer Asked by Jeff on July 26, 2023
Q: I am up 100% on NVO. LLY has just received an upgrade and am wondering if I should take profits on NVO and move into LLY or just add some LLY and let NVO run. In your opinion are they too much alike to hold both?

Thank you

Mike
Read Answer Asked by Michael on July 20, 2023
Q: WELL appears to be a reasonable recession-resistant investment, and management seems solid to me. Questions:

- How similar is TDOC's business model in comparison, and can WELL differentiate itself enough with its expansion into the U.S. ?

- Can 5i envision any other different avenues of growth for WELL to expand it's offerings within the health sector ?

- Is its current balance sheet sound, and can this company endure a rising interest rate environment ?


Thanks.
Read Answer Asked by James on July 20, 2023
Q: Pls ahare your favorite health stocks or ETFs. I am looking for growth - medium risk. Thanks
Read Answer Asked by gary on July 18, 2023
Q: Would advise your top picks in Us health care stocks or STFs with moderate risk. Yhanks
Read Answer Asked by gary on July 18, 2023
Q: Inmode's share price recently had a sizeable increase, presumably due the guidance it released. Would you expect a further increase based on that guidance? What are the prospects for the company going forward and where do you see the share price going from here, for the short as well as long term? Many thanks for your excellent service.
Read Answer Asked by Leonard on July 18, 2023
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!